China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A real world study on the mechanism of SGLT-2 inhibitors in reducing the diabetes-induced chronic heart failure via inhibition of sympathetic nervous system'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130437
Registration Time: 2026/08/20
Type: Observational study
Primary Sponsor: Shanghai Pudong Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334546
Published by HT Digital Content Services with permission from Health Daily Digest....